{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["4(6)"],"submitter":["Sala M"],"funding":["Association Française pour l'Etude du Foie"],"pubmed_abstract":["Until recently, 10% of hepatocellular adenomas (HCAs) remained unclassified (UHCA). Among the UHCAs, the sonic hedgehog HCA (shHCA) was defined by focal deletions that fuse the promoter of Inhibin beta E chain with GLI1. Prostaglandin D2 synthase was proposed as immunomarker. In parallel, our previous work using proteomic analysis showed that most UHCAs constitute a homogeneous subtype associated with overexpression of argininosuccinate synthase (ASS1). To clarify the use of ASS1 in the HCA classification and avoid misinterpretations of the immunohistochemical staining, the aims of this work were to study (1) the link between shHCA and ASS1 overexpression and (2) the clinical relevance of ASS1 overexpression for diagnosis. Molecular, proteomic, and immunohistochemical analyses were perform"],"journal":["Hepatology communications"],"pagination":["809-824"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7262286"],"repository":["biostudies-literature"],"pubmed_title":["ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice."],"pmcid":["PMC7262286"],"pubmed_authors":["Blanc JF","Crawford J","Miller G","Quaglia A","Castain C","Trillaud H","Di Tommaso S","Sciarra A","le Bail B","Chiche L","Raymond AA","Possenti L","Saltel F","Dupuy JW","Yeh MM","Fan C","Pitard V","Balabaud C","Leste-Lasserre T","Dourthe C","Thung S","Gouw ASH","Ferrell LD","Clouston AD","Harada K","Bioulac-Sage P","Frulio N","Paradis V","Dugot-Senant N","Gonzales D","Sala M","Han J","Laurent C","Nakanuma Y","Sempoux C","Huan J"],"additional_accession":[]},"is_claimable":false,"name":"ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.","description":"Until recently, 10% of hepatocellular adenomas (HCAs) remained unclassified (UHCA). Among the UHCAs, the sonic hedgehog HCA (shHCA) was defined by focal deletions that fuse the promoter of Inhibin beta E chain with GLI1. Prostaglandin D2 synthase was proposed as immunomarker. In parallel, our previous work using proteomic analysis showed that most UHCAs constitute a homogeneous subtype associated with overexpression of argininosuccinate synthase (ASS1). To clarify the use of ASS1 in the HCA classification and avoid misinterpretations of the immunohistochemical staining, the aims of this work were to study (1) the link between shHCA and ASS1 overexpression and (2) the clinical relevance of ASS1 overexpression for diagnosis. Molecular, proteomic, and immunohistochemical analyses were perform","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jun","modification":"2026-04-14T17:19:21.742Z","creation":"2020-06-05T07:06:56Z"},"accession":"S-EPMC7262286","cross_references":{"pubmed":["32490318"],"doi":["10.1002/hep4.1514"]}}